
Susan T Tran
Examiner (ID: 251, Phone: (571)272-0606 , Office: P/1615 )
| Most Active Art Unit | 1615 |
| Art Unit(s) | 1618, 1615 |
| Total Applications | 1909 |
| Issued Applications | 1053 |
| Pending Applications | 242 |
| Abandoned Applications | 650 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 6749939
[patent_doc_number] => 20030044459
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-03-06
[patent_title] => 'Biomodulated multiparticulate formulations'
[patent_app_type] => new
[patent_app_number] => 10/228637
[patent_app_country] => US
[patent_app_date] => 2002-08-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 1774
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0044/20030044459.pdf
[firstpage_image] =>[orig_patent_app_number] => 10228637
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/228637 | Biomodulated multiparticulate formulations | Aug 26, 2002 | Abandoned |
Array
(
[id] => 6692258
[patent_doc_number] => 20030039690
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-02-27
[patent_title] => 'Controlled release arginine alpha ketoglutarate'
[patent_app_type] => new
[patent_app_number] => 10/226646
[patent_app_country] => US
[patent_app_date] => 2002-08-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9358
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 57
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0039/20030039690.pdf
[firstpage_image] =>[orig_patent_app_number] => 10226646
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/226646 | Controlled release arginine alpha ketoglutarate | Aug 22, 2002 | Issued |
Array
(
[id] => 6324392
[patent_doc_number] => 20020197326
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-12-26
[patent_title] => 'Injectable and swellable microspheres for dermal augmentation'
[patent_app_type] => new
[patent_app_number] => 10/222819
[patent_app_country] => US
[patent_app_date] => 2002-08-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8309
[patent_no_of_claims] => 52
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0197/20020197326.pdf
[firstpage_image] =>[orig_patent_app_number] => 10222819
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/222819 | Injectable and swellable microspheres for dermal augmentation | Aug 18, 2002 | Issued |
Array
(
[id] => 6668396
[patent_doc_number] => 20030113379
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-06-19
[patent_title] => 'Biodegradable composite matrix for enhancing angiogenesis and method for producing the same'
[patent_app_type] => new
[patent_app_number] => 10/219674
[patent_app_country] => US
[patent_app_date] => 2002-08-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 2672
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0113/20030113379.pdf
[firstpage_image] =>[orig_patent_app_number] => 10219674
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/219674 | Biodegradable composite matrix for enhancing angiogenesis and method for producing the same | Aug 15, 2002 | Abandoned |
Array
(
[id] => 6683864
[patent_doc_number] => 20030119728
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-06-26
[patent_title] => 'Stable, nasally, orally or sublingually applicable pharmaceutical preparation'
[patent_app_type] => new
[patent_app_number] => 10/203614
[patent_app_country] => US
[patent_app_date] => 2002-08-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 4977
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0119/20030119728.pdf
[firstpage_image] =>[orig_patent_app_number] => 10203614
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/203614 | Stable, nasally, orally or sublingually applicable pharmaceutical preparation | Aug 15, 2002 | Abandoned |
Array
(
[id] => 6809648
[patent_doc_number] => 20030199587
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-10-23
[patent_title] => 'Levothyroxine compositions having unique Cmax properties'
[patent_app_type] => new
[patent_app_number] => 10/218951
[patent_app_country] => US
[patent_app_date] => 2002-08-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 18507
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0199/20030199587.pdf
[firstpage_image] =>[orig_patent_app_number] => 10218951
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/218951 | Levothyroxine compositions having unique Cmax properties | Aug 13, 2002 | Abandoned |
Array
(
[id] => 7679082
[patent_doc_number] => 20030195254
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-10-16
[patent_title] => 'Levothyroxine compositions having unique triiodothyronine Tmax properties'
[patent_app_type] => new
[patent_app_number] => 10/218959
[patent_app_country] => US
[patent_app_date] => 2002-08-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 18566
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0195/20030195254.pdf
[firstpage_image] =>[orig_patent_app_number] => 10218959
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/218959 | Levothyroxine compositions having unique triiodothyronine Tmax properties | Aug 13, 2002 | Abandoned |
Array
(
[id] => 6796452
[patent_doc_number] => 20030175326
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-09-18
[patent_title] => 'Palatable controlled-release formulations for companion animals'
[patent_app_type] => new
[patent_app_number] => 10/213162
[patent_app_country] => US
[patent_app_date] => 2002-08-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 14386
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0175/20030175326.pdf
[firstpage_image] =>[orig_patent_app_number] => 10213162
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/213162 | Palatable controlled-release formulations for companion animals | Aug 5, 2002 | Abandoned |
Array
(
[id] => 6779196
[patent_doc_number] => 20030050278
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-03-13
[patent_title] => 'Agent and food for inhibiting IgE antibody'
[patent_app_type] => new
[patent_app_number] => 10/212071
[patent_app_country] => US
[patent_app_date] => 2002-08-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 2440
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0050/20030050278.pdf
[firstpage_image] =>[orig_patent_app_number] => 10212071
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/212071 | Agent and food for inhibiting IgE antibody | Aug 5, 2002 | Abandoned |
Array
(
[id] => 6760824
[patent_doc_number] => 20030124185
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-07-03
[patent_title] => 'Pharmaceutical formulation containing opioid agonist, opioid antagonist and bittering agent'
[patent_app_type] => new
[patent_app_number] => 10/213921
[patent_app_country] => US
[patent_app_date] => 2002-08-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23699
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0124/20030124185.pdf
[firstpage_image] =>[orig_patent_app_number] => 10213921
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/213921 | Pharmaceutical formulation containing opioid agonist, opioid antagonist and bittering agent | Aug 5, 2002 | Issued |
Array
(
[id] => 553842
[patent_doc_number] => 07157103
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-01-02
[patent_title] => 'Pharmaceutical formulation containing irritant'
[patent_app_type] => utility
[patent_app_number] => 10/214410
[patent_app_country] => US
[patent_app_date] => 2002-08-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20124
[patent_no_of_claims] => 43
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 57
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/157/07157103.pdf
[firstpage_image] =>[orig_patent_app_number] => 10214410
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/214410 | Pharmaceutical formulation containing irritant | Aug 5, 2002 | Issued |
Array
(
[id] => 6782652
[patent_doc_number] => 20030064099
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-04-03
[patent_title] => 'Pharmaceutical formulation containing bittering agent'
[patent_app_type] => new
[patent_app_number] => 10/213920
[patent_app_country] => US
[patent_app_date] => 2002-08-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20447
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0064/20030064099.pdf
[firstpage_image] =>[orig_patent_app_number] => 10213920
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/213920 | Pharmaceutical formulation containing bittering agent | Aug 5, 2002 | Issued |
Array
(
[id] => 6773847
[patent_doc_number] => 20030017185
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-01-23
[patent_title] => 'Cosmetic composition'
[patent_app_type] => new
[patent_app_number] => 10/211589
[patent_app_country] => US
[patent_app_date] => 2002-08-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4834
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0017/20030017185.pdf
[firstpage_image] =>[orig_patent_app_number] => 10211589
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/211589 | Cosmetic composition | Aug 4, 2002 | Issued |
Array
(
[id] => 6682775
[patent_doc_number] => 20030118639
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-06-26
[patent_title] => 'Controlled release pharmaceutical composition'
[patent_app_type] => new
[patent_app_number] => 10/212484
[patent_app_country] => US
[patent_app_date] => 2002-08-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 4580
[patent_no_of_claims] => 42
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0118/20030118639.pdf
[firstpage_image] =>[orig_patent_app_number] => 10212484
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/212484 | Controlled release pharmaceutical composition | Aug 4, 2002 | Issued |
Array
(
[id] => 697995
[patent_doc_number] => 07067152
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-06-27
[patent_title] => 'Multi component moisture triggered controlled release system that imparts long lasting cooling sensation on the target site and/or provides high impact fragrance or flavor burst'
[patent_app_type] => utility
[patent_app_number] => 10/211727
[patent_app_country] => US
[patent_app_date] => 2002-08-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 9463
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 222
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/067/07067152.pdf
[firstpage_image] =>[orig_patent_app_number] => 10211727
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/211727 | Multi component moisture triggered controlled release system that imparts long lasting cooling sensation on the target site and/or provides high impact fragrance or flavor burst | Aug 1, 2002 | Issued |
Array
(
[id] => 6749938
[patent_doc_number] => 20030044458
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-03-06
[patent_title] => 'Oral dosage form comprising a therapeutic agent and an adverse-effect agent'
[patent_app_type] => new
[patent_app_number] => 10/208817
[patent_app_country] => US
[patent_app_date] => 2002-08-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 11154
[patent_no_of_claims] => 79
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0044/20030044458.pdf
[firstpage_image] =>[orig_patent_app_number] => 10208817
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/208817 | Oral dosage form comprising a therapeutic agent and an adverse-effect agent | Jul 31, 2002 | Abandoned |
Array
(
[id] => 6324337
[patent_doc_number] => 20020197319
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-12-26
[patent_title] => 'Method for coating pharmaceutical dosage forms'
[patent_app_type] => new
[patent_app_number] => 10/209463
[patent_app_country] => US
[patent_app_date] => 2002-07-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2715
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 106
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0197/20020197319.pdf
[firstpage_image] =>[orig_patent_app_number] => 10209463
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/209463 | Method for coating pharmaceutical dosage forms | Jul 30, 2002 | Issued |
Array
(
[id] => 4612261
[patent_doc_number] => 07988995
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2011-08-02
[patent_title] => 'Pharmaceutical compositions for lipophilic drugs'
[patent_app_type] => utility
[patent_app_number] => 10/207146
[patent_app_country] => US
[patent_app_date] => 2002-07-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7149
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 121
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/988/07988995.pdf
[firstpage_image] =>[orig_patent_app_number] => 10207146
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/207146 | Pharmaceutical compositions for lipophilic drugs | Jul 29, 2002 | Issued |
Array
(
[id] => 6324300
[patent_doc_number] => 20020197313
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-12-26
[patent_title] => 'Unit dosage forms for the treatment of herpes simplex'
[patent_app_type] => new
[patent_app_number] => 10/209432
[patent_app_country] => US
[patent_app_date] => 2002-07-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8316
[patent_no_of_claims] => 69
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0197/20020197313.pdf
[firstpage_image] =>[orig_patent_app_number] => 10209432
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/209432 | Unit dosage forms for the treatment of herpes simplex | Jul 29, 2002 | Issued |
Array
(
[id] => 6842601
[patent_doc_number] => 20030147948
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-08-07
[patent_title] => 'Composition comprises sustained-release fine particles and manufacturing method thereof'
[patent_app_type] => new
[patent_app_number] => 10/206010
[patent_app_country] => US
[patent_app_date] => 2002-07-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 17645
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 79
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0147/20030147948.pdf
[firstpage_image] =>[orig_patent_app_number] => 10206010
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/206010 | Composition comprises sustained-release fine particles and manufacturing method thereof | Jul 24, 2002 | Issued |